Pharma Equity Group A/S (CPSE: PEG)
Health Care · Pharmaceuticals · DK
Dkr0.08
-10.13% today · -39.3% 1Y
Pharma Equity Group A/S (CPSE: PEG) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $15.52M and employs 5 people.
Over the last twelve months the share price has lost 39.3%, trading between 0.06 and 0.15.
Tweenvest scores Pharma Equity Group A/S across four factors: quality 20/100. Its strongest factor is quality.
PEG price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $15.52M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.02
- Dividend yield
- —
- Beta (5Y)
- 1.01
- 52-week high
- Dkr0.15
- 52-week low
- Dkr0.06
- Avg volume (3M)
- —
- Shares outstanding
- 1.23B
- Employees
- 5
- Next earnings
- —
About Pharma Equity Group A/S
Operating from Hørsholm, Denmark, Pharma Equity Group A/S is an investment firm primarily focused on the life sciences industry. The company strategically provides early-stage capital to ventures that are developing advanced technologies and treatments designed to improve human health and elevate the quality of life.
- Founded
- 2002
- Listed since
- May 16, 2023
- Exchange
- OMX Nordic Exchange Copenhagen
- Currency
- DKK
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,257.35 | +0.16% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.37 | +0.42% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.90 | -1.25% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.48 | -0.76% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.15 | +0.29% |
Figures last refreshed Aug 18, 2026.